India’s Drug Industry At Loggerheads Over Government-Ordered Price Cuts
This article was originally published in The Pink Sheet Daily
Executive Summary
India’s drug industry is still up in arms over the country’s new pricing policy, and conflict between drug makers and retailers is escalating as both camps try to figure out how to make a profit under the new policy.